KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-cash Items: 2011-2024

Historic Non-cash Items for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to $3.5 million.

  • TherapeuticsMD's Non-cash Items rose 91.33% to $949,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 1164.38%. This contributed to the annual value of $3.5 million for FY2024, which is 1060.67% up from last year.
  • Per TherapeuticsMD's latest filing, its Non-cash Items stood at $3.5 million for FY2024, which was up 1,060.67% from $300,000 recorded in FY2023.
  • TherapeuticsMD's 5-year Non-cash Items high stood at $3.5 million for FY2024, and its period low was $152,000 during FY2020.
  • Moreover, its 3-year median value for Non-cash Items was $700,000 (2022), whereas its average is $1.5 million.
  • In the last 5 years, TherapeuticsMD's Non-cash Items slumped by 99.16% in 2020 and then spiked by 1,060.67% in 2024.
  • Yearly analysis of 5 years shows TherapeuticsMD's Non-cash Items stood at $152,000 in 2020, then skyrocketed by 121.05% to $336,000 in 2021, then spiked by 108.33% to $700,000 in 2022, then tumbled by 57.14% to $300,000 in 2023, then surged by 1,060.67% to $3.5 million in 2024.